Live Debate: Valganciclovir Dosing in Moderate and High CMV Risk SOT Recipients: 450 mg Daily vs. 900 mg Daily
March 22, 2018 from 02:00pm to 03:00pm EDT
Jennifer-Trofe Clark, PharmD, BCPS • University of Pennsylvania Hospital, Philadelphia
Steven Gabardi, PharmD, BCPS • Brigham & Women's Hospital, Boston
Camille Nelson Kotton, MD • Massachusetts General Hospital, Boston
This webinar is open to members and non-members.